These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8378415)

  • 1. Polydipsia induced by fluvoxamine.
    Benazzi F; Mazzoli M
    Pharmacopsychiatry; 1993 Mar; 26(2):63. PubMed ID: 8378415
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluvoxamine-induced acute exacerbation in residual schizophrenia.
    Rocco PL; De Leo D
    Pharmacopsychiatry; 1992 Sep; 25(5):245. PubMed ID: 1409869
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluvoxamine: clinical trials and clinical use.
    Freeman CP
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):19-25. PubMed ID: 1931932
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fluvoxamine. Study of treatment effect on a group of 189 hospitalized patients with depression].
    Peyre F; Verdoux H; Bourgeois M
    Encephale; 1992 Jan; 18 Spec No 1():73-4. PubMed ID: 1600911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPMS under antidepressive therapy with fluvoxamine and concomitant antibiotic therapy with clindamycin.
    Jakob F; Wolf J
    Pharmacopsychiatry; 2007 May; 40(3):129. PubMed ID: 17541891
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacology of serotonin uptake inhibitors: focus on fluvoxamine.
    Hrdina PD
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):10-8. PubMed ID: 1931931
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacotherapy of depression.
    Joffe RT
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):4-9. PubMed ID: 1931936
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluvoxamine: a review of the controlled trials in depression.
    Ware MR
    J Clin Psychiatry; 1997; 58 Suppl 5():15-23. PubMed ID: 9184623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyskinesia associated with fluvoxamine.
    Arya DK; Szabadi E
    J Clin Psychopharmacol; 1993 Oct; 13(5):365-6. PubMed ID: 8227498
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The status of fluvoxamine among the antidepressive agents].
    Svestka J; Cesková E; Rysánek R; Obrovská V; Kamenická V
    Cesk Psychiatr; 1992 Sep; 88(5):209-19. PubMed ID: 1451197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notes on the use of fluvoxamine as treatment of depression in HIV-1-infected subjects.
    Grassi B; Gambini O; Scarone S
    Pharmacopsychiatry; 1995 May; 28(3):93-4. PubMed ID: 7568371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvoxamine in the treatment of depressive illness. A series of double-blind hospital based comparative studies carried out in the UK.
    Whitehead AM; Ashford JJ
    Br J Clin Pract; 1992; 46(1):21-3. PubMed ID: 1419548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients.
    Laird LK; Lydiard RB; Morton WA; Steele TE; Kellner C; Thompson NM; Ballenger JC
    J Clin Psychiatry; 1993 Jun; 54(6):224-8. PubMed ID: 8331091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe myoclonus produced by fluvoxamine.
    Bauer M
    J Clin Psychiatry; 1995 Dec; 56(12):589-90. PubMed ID: 8530337
    [No Abstract]   [Full Text] [Related]  

  • 16. Extrapyramidal symptoms in a patient treated with fluvoxamine.
    Wils V
    J Neurol Neurosurg Psychiatry; 1992 Apr; 55(4):330-1. PubMed ID: 1583525
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrocardiographic findings during extended clinical trials of fluvoxamine in depression: one years experience.
    Hochberg HM; Kanter D; Houser VP
    Pharmacopsychiatry; 1995 Nov; 28(6):253-6. PubMed ID: 8773292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine-induced theophylline toxicity.
    DeVane CL; Markowitz JS; Hardesty SJ; Mundy S; Gill HS
    Am J Psychiatry; 1997 Sep; 154(9):1317-8. PubMed ID: 9286199
    [No Abstract]   [Full Text] [Related]  

  • 19. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
    Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA; Bullock T; Fineberg N
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.